Skip to main content
Erschienen in:

01.04.2015 | short review

Optimal follow-up of ovarian cancer patients

verfasst von: Eduard Vrdoljak, MD, PhD, Branka Petrić Miše, MD, Tihana Boraska Jelavić, MD, PhD, Snježana Tomić, MD, PhD, Dinka Šundov, MD, PhD, Ante Strikić, MD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Gynecological malignancies account for roughly 10 % of all cancers in women with ovarian cancer as leading cause of death due to gynecological tumors. Surveillance programs of ovarian cancer are primarily based on recurrence rates, timing of recurrence, salvage options, and chances for cure of patient with recurrence. Since there is no prospective, high evidence data on optimal surveillance program after primary treatment of patients with ovarian cancer recommendations are based on review of retrospective data sets. From all the diagnostic tools available, history taking and clinical examination, including gynecological examination, still contribute to the greatest number of recurrence detections. Radiologic and laboratory tests are usually employed when a suspicion of recurrence is raised. Follow-up plan should be tailored according to the estimated risk of relapse for individual patient.
Literatur
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Metadaten
Titel
Optimal follow-up of ovarian cancer patients
verfasst von
Eduard Vrdoljak, MD, PhD
Branka Petrić Miše, MD
Tihana Boraska Jelavić, MD, PhD
Snježana Tomić, MD, PhD
Dinka Šundov, MD, PhD
Ante Strikić, MD
Publikationsdatum
01.04.2015
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2015
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-014-0188-y